Indolizine compounds patent for mental disorders inflammation
Summary
Indolizine compounds patent for mental disorders inflammation
Source document (simplified)
INDOLIZINE COMPOUNDS FOR THE TREATMENT OF MENTAL DISORDERS OR INFLAMMATION
Publication EP4499058A2 Kind: A2 Mar 18, 2026
Applicants
Tactogen Inc.
Inventors
BAGGOTT, Matthew, J.
IPC Classifications
A61K 31/137 20060101AFI20260211BHEP A61K 31/13 20060101ALI20260211BHEP A61K 31/395 20060101ALI20260211BHEP A61K 31/135 20060101ALI20260211BHEP A61K 31/4162 20060101ALI20260211BHEP A61K 31/33 20060101ALI20260211BHEP C07D 471/04 20060101ALI20260211BHEP A61P 25/00 20060101ALI20260211BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Source
Classification
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Pharma (A61K) publishes new changes.